| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/06/2002 | WO2002067978A1 Chondrogenic potential of human bone marrow-derived cd105+ cells by bmp |
| 09/06/2002 | WO2002067971A2 Use of endostatin in the treatment of ocular neovascularization |
| 09/06/2002 | WO2002067970A1 TRYPTOPHANYL-tRNA SYNTHETASE DERIVED POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 09/06/2002 | WO2002067958A1 Method for determining efficacy of reverse cholesterol transport enhancing agents |
| 09/06/2002 | WO2002067861A2 Oncolytic adenoviral vectors |
| 09/06/2002 | WO2002067860A2 Selection by mirror image display |
| 09/06/2002 | WO2002067857A2 Modified annexin proteins and methods for preventing thrombosis |
| 09/06/2002 | WO2002067771A2 Chemokine receptors and disease |
| 09/06/2002 | WO2002067669A2 Primordial germ cell-based germ line production of birds |
| 09/06/2002 | WO2002067668A1 Schizophrenia-like mental disease model animal, method of constructing the same and use thereof |
| 09/06/2002 | WO2002067665A2 Cloning of transgenic animals comprising artificial chromosomes |
| 09/06/2002 | WO2002067663A1 Methods for effectuating mrna-mediated transfer of genetic information into plants and products of the same |
| 09/06/2002 | WO2002067662A1 Manipulation of sucrose synthase genes to improve stalk and grain quality |
| 09/06/2002 | WO2002052026A3 Nucleic acid integration in eukaryotes |
| 09/06/2002 | WO2002048182A3 Interferon-alpha induced gene |
| 09/06/2002 | WO2002046450A3 Method for generating a library of mutant oligonucleotides using the linear cyclic amplification reaction |
| 09/06/2002 | WO2002046415A9 Polynucleotide and polypeptide sequences of putative transporters and ion channells |
| 09/06/2002 | WO2002046216A3 Human sprouty-4 polypeptide |
| 09/06/2002 | WO2002044376A8 Modulation of gene expression using insulator binding proteins |
| 09/06/2002 | WO2002043654A3 Pharmaceutical composition and method for treatment of brain injury, spinal cord injury, stroke, neurodegenerative disease and other conditions |
| 09/06/2002 | WO2002042425A3 Antisense modulation of mp-1 expression |
| 09/06/2002 | WO2002042326A8 A method of expression and agents identified thereby |
| 09/06/2002 | WO2002040517A3 M. tuberculosis chaperonin 60.1 and uses thereof |
| 09/06/2002 | WO2002040037A3 M. tuberculosis chaperonin 60.1 and uses thereof |
| 09/06/2002 | WO2002038728A3 Method for removing a universal linker from an oligonucleotide |
| 09/06/2002 | WO2002038585A3 Haplotypes of the gss gene |
| 09/06/2002 | WO2002036817A3 Method and kit to determine lp-pla2 polymorphic variants associated with susceptibility to atherosclerosis |
| 09/06/2002 | WO2002036809A3 Antisense modulation of sr-cyp expression |
| 09/06/2002 | WO2002036792A3 Dna expression vectors |
| 09/06/2002 | WO2002036771A3 Imaging, diagnosis and treatment of disease |
| 09/06/2002 | WO2002036632A8 Single nucleotide polymorphisms in nucleic acids encoding human olfactory receptor-like polypeptides |
| 09/06/2002 | WO2002034923A3 Monocotyledon plant cells and plants which synthesise modified starch |
| 09/06/2002 | WO2002031182A3 Method and apparatus for reading reporter labeled beads |
| 09/06/2002 | WO2002020842A8 System, method and apparatus for transgenic and targeted mutagenesis screening |
| 09/06/2002 | WO2002016574A3 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type |
| 09/06/2002 | WO2002012901A3 Use of grf1 protein for screening molecules |
| 09/06/2002 | WO2002012534A3 Bio-intermediates for use in the chemical synthesis of polyketides |
| 09/06/2002 | WO2002010217A3 Endothelial cell expression patterns |
| 09/06/2002 | WO2002006465A9 7677, a novel human atpase family member and uses therefor |
| 09/06/2002 | WO2002004672A3 Diagnostic method for the identification of foetal dna in a maternal sample |
| 09/06/2002 | WO2002002629A3 Grf2-binding proteins and applications thereof |
| 09/06/2002 | WO2002000879A3 Methods for producing modified glycoproteins |
| 09/06/2002 | WO2002000687A3 Antimicrobial peptides and methods of use thereof |
| 09/06/2002 | WO2001098363A3 Peptides for use in the immunotherapy of renal cell carcinoma |
| 09/06/2002 | WO2001098334A3 Streptococcus antigens |
| 09/06/2002 | WO2001092565A3 Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription |
| 09/06/2002 | WO2001092523A3 Human polynucleotides and polypeptides encoded thereby |
| 09/06/2002 | WO2001091805A3 Compounds for targeting endothelial cells |
| 09/06/2002 | WO2001085932A3 Immunogenic polypeptides encoded by mage minigenes and uses thereof |
| 09/06/2002 | WO2001085785A3 Ph domain-interacting protein |
| 09/06/2002 | WO2001085780A3 Nucleic acid binding polypeptides |
| 09/06/2002 | WO2001083752A3 23949 and 32391, human ion channels and uses thereof |
| 09/06/2002 | WO2001079515A3 Methods of identifying transgenic plants using morphological markers |
| 09/06/2002 | WO2001073093A3 Cell-specific adenovirus vectors comprising an internal ribosome entry site |
| 09/06/2002 | WO2001072995A3 Methods of producing a library and methods of selecting polynucletides |
| 09/06/2002 | WO2001072822B1 Genes involved in intestinal inflammatory diseases and use thereof |
| 09/06/2002 | WO2001070773A3 Insecticidal peptides and methods for using same |
| 09/06/2002 | WO2001064738A3 Heparin-binding amino acid sequences derived from human proteins facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/06/2002 | WO2001062965A3 Differential expression screening method |
| 09/06/2002 | WO2001061038A3 Method for detecting a biological entity in a sample |
| 09/06/2002 | WO2001058915A8 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 09/06/2002 | WO2001051664A3 Method of detecting and characterizing a neoplasm |
| 09/06/2002 | WO2001049834A3 Preparation of deallergenized patatin proteins and patatin permutein proteins |
| 09/06/2002 | WO2001049687A9 Cyclohexene nucleic acids |
| 09/06/2002 | WO2001048485A9 Selecting library members capable of binding to epitopes |
| 09/06/2002 | WO2001048247A3 METHOD FOR GENERATION OF LONGER cDNA FRAGMENTS FROM SAGE TAGS FOR GENE IDENTIFICATION |
| 09/06/2002 | WO2001048230A9 Modified dhps genes |
| 09/06/2002 | WO2001046253A9 A new polypeptide-calcitonin 11 and the polynucleotide encoding it |
| 09/06/2002 | WO2001032614A9 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 09/06/2002 | WO2001031040A9 Host-vector systems in order to over-produce thermolabile enzymes originating from psychrophilic organisms |
| 09/06/2002 | WO2001031021A9 Multiple sclerosis-related superantigen |
| 09/06/2002 | WO2001030851A9 Idiotype vaccines |
| 09/06/2002 | WO2001027291A9 Design of a polyepitopic construct for the induction of hla-a2.1 restricted hiv 1 specific ctl responses using hhd mice |
| 09/06/2002 | WO2001025449A9 Novel immobilizable amylosucrase, the use thereof and method for producing poly(1,4-alpha-glucan) |
| 09/06/2002 | WO2001024681A9 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same |
| 09/06/2002 | WO2001023606A3 Nucleic acid molecules for detecting bacteria and phylogenetic units of bacteria |
| 09/06/2002 | WO2001018546A9 Screening for inhibitors of 'paired helical filaments' |
| 09/06/2002 | WO2001018233A9 Screening for inhibitors of lumazine synthase |
| 09/06/2002 | WO2001018199A9 Chimaeric plant viruses with mucin peptides |
| 09/06/2002 | WO2001018189A9 Method for expressing exogenous sequences in mammalian cells |
| 09/06/2002 | WO2001018035A9 Muc-1 derived peptides |
| 09/06/2002 | WO2001016177A9 Mouse g-protein coupled 7 transmembrane receptor, canoman |
| 09/06/2002 | WO2001014581A9 Hdac4 and hdac5 in the regulation of cardiac gene expression |
| 09/06/2002 | WO2001014529A9 Compositions and methods for improved cell culture |
| 09/06/2002 | WO2001012674A9 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 09/06/2002 | WO2001007627A9 Drosophila recombination-associated protein and methods for use |
| 09/06/2002 | WO2001007598A9 EXPRESSION CLONING USING A TAGGED cDNA LIBRARY |
| 09/06/2002 | WO2001005945A9 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 09/06/2002 | WO2001005944A9 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 09/06/2002 | WO2001004334A9 Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 coxsacki adenovirus receptor (car) |
| 09/06/2002 | WO2000078955A9 Epithelial cell growth inhibitors |
| 09/06/2002 | WO2000073462A9 Attenuated mutant enteropathogenic e. coli (epec) strains, process for their production and their use |
| 09/06/2002 | WO2000067761A9 Compositions and methods for identifying antigens which elicit an immune response |
| 09/06/2002 | WO2000065062A9 Genome sequence and polypeptides of pyrococcus abissy, fragment and uses thereof |
| 09/06/2002 | CA2846761A1 Enzymes having dehalogenase activity and methods of use thereof |
| 09/06/2002 | CA2833423A1 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | CA2674673A1 Modified and stabilized gdf propeptides and uses thereof |
| 09/06/2002 | CA2477043A1 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer |
| 09/06/2002 | CA2444493A1 Method for identifying biologically active structures of microbial pathogens |
| 09/06/2002 | CA2439492A1 Tri-hybrid melanoma antigen |